NeuroOne Medical Technologies Corp (NASDAQ:NMTC) currently has a daily average trading volume of 167.30K but it saw 244614 shares traded in last market. With a market cap of 33.31M USD, the company’s current market price of $1.08 came falling about -5.26 while comparing to the previous closing price of $1.14. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.59 and as low as $0.55. In the recent trading on the day, stock has struck highest price mark of $0.976 while lowest mark touched by it was $1.12.
Taking a look at 20-day trading activity of NeuroOne Medical Technologies Corp (NMTC) gives us an average price of $0.8405, while its current price level is -32.08% below from 52-week high level whereas it is 96.01% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.8045 while that of 200 days or SMA-200 reads an average of $0.9118. A closer look into the stock’s movement over the week reveals that its volatility is standing at 13.52% during that period while stretching the period over a month that decreases to 13.40%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 69.21 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Craig Hallum which downgraded the stock as “Hold” in its note to investors issued on March 29, 2022, recommending a price target of between $6 and $2 for it.
Over the week, NMTC’s stock price is moving 30.77% up while it is 83.05% when we observe its performance for the past one month. Year-to-date it is 30.77% up and over the past year, the stock is showing a downside performance of -26.03%.
Currently, NeuroOne Medical Technologies Corp’s total number of outstanding shares is 30.82M. Company’s return on investment (ROI) stands at -1211.93% and return on equity (ROE) at -348.39%. Stock’s beta reads 0.63. Stock has a price to book (P/B) ratio of 40.49 while price to sale or P/S ratio amounts to 9.65. Its return on asset (ROA) is -182.93% on average.
